Cryselle Kit
NDC 0480-3493
Product Information
Cryselle (norgestrel and ethinyl estradiol) is a ANDA-approved product labeled by Teva Pharmaceuticals, Inc.. This combination hormone medication is used to prevent pregnancy. It is supplied as a white kit for oral administration. This product entry covers the primary NDC 0480-3493 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
GREEN (C48329 - LIGHT GREEN)
C33;TV
T;PL2
Code Structure Chart
Product Details
What is NDC 0480-3493?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- NORGESTREL (UNII: 3J8Q1747Z2)
- NORGESTREL (UNII: 3J8Q1747Z2) (Active Moiety)
- ETHINYL ESTRADIOL (UNII: 423D2T571U)
- ETHINYL ESTRADIOL (UNII: 423D2T571U) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- STARCH, CORN (UNII: O8232NY3SJ)
- D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)
- FD&C BLUE NO. 1 ALUMINUM LAKE (UNII: J9EQA3S2JM)
- FD&C YELLOW NO. 6 ALUMINUM LAKE (UNII: GYP6Z2JR6Q)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311359 - norgestrel 0.3 MG / ethinyl estradiol 0.03 MG Oral Tablet
- RxCUI: 311359 - ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet
- RxCUI: 311359 - ethinyl estradiol 30 MCG / norgestrel 0.3 MG Oral Tablet
- RxCUI: 748797 - inert 1 MG Oral Tablet
- RxCUI: 748797 - inert ingredients 1 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.